3. cvs Flashcards
…………………………………….. is the major direct consequence of diminished cardiac output(CO)
Decreased exercise tolerance with rapid muscular fatigue
Therapeutic strategies
Removal of retained salt and water: diuretics
Reduction of after load and salt and water retention: ACEIs
Reduction of excessive sympathetic stimulation: beta blockers
Reduction of preload or after load: vasodilators
Direct augmentation of depressed cardiac contractility: cardiac glycosides
Approaches of therapy:2
non-pharmacological and pharmacological
Drugs with positive inotropic actions:
Cardiac glycosides(CGs)
Beta agonists, and
Phosphodiesterase inhibitors
Drugs without positive inotropic actions:
diuretics,
ACEIs/ARBs,
beta blockers,
vasodilators, and
aldosterone antagonists
Drugs for symptomatic relief:
CGs,
beta agonists,
PDE inhibitors,
diuretics
Drugs for slowing disease progression:
ACEIs/ARBs,
beta blockers,
aldosterone antagonists,
The hydroxyl groups and other substitutions found on the aglycone determine
The hydroxyl groups and other substitutions found on the aglycone determine its polarity
Digoxin has one additional hydroxyl group than digitoxin
mechanism of action of digoxin
Mechanism of action: Inhibition of Na+/K+-ATPase → increase in intracellular Na+→ alters the driving force for sodium-calcium exchange by the exchanger→ increase in intracellular calcium → increased contractility
digoxin effects in heart
main positive inotropic
Heart rate decreases due to improved performance of the heart and an increased vagal tone(negative chronotropy)
Hinder the conduction of excitation(negative dromotropy)
Promote the formation of heterotopic excitations(positive bathmotropy)—which can lead to ventricular extrasytoles and ventr. tachycardia
time takes digoxin to work
Binding CGs to Na+ K+ ATPase is slow
Moreover after Na+ K+ ATPase inhibition, Ca++ loading occurs gradually
Thus inotropic effect of digitalis takes hours to develop, even after i.v. administration
effect on blood vessels digoxin
a net decrease in peripheral resistance and improved venous tone
effect on kidney digoxin
diuresis secondary to improvement in circulation and renal perfusion(retained salt and water is gradually excreted)
No diuresis occurs in normal individuals or edema due to other causes
CNS effects of digoxin
CNS: higher doses cause CTZ activation resulting nausea and vomiting
Still higher doses: hyperapnea, confusion, disorientation, visual disturbances
Are also useful in atrial arrhythmias(atrial flutter and fibrillation)
digoxin
slow and large doses
Slow approach of digitalization is safe and employed when symptoms are mild
Large loading dose(divided in three or four portions given over 24-36 hours) followed by maintenance doses can be employed when more rapid effect is required
Adverse effects
GI
visual
CNS
cardiac
GI disturbances: anorexia, nausea, vomiting, diarrhea(gastric irritation & CTZ activation)
Visual disturbances: disturbed color vision
CNS effects: delirium, fatigue, confusion, dizziness, abnormal dreams
Cardiac effects: different arrhythmias
Management of toxicity: 4
Withdrawal of the glycoside for extracardiac effects may be enough
Potassium supplementation corrects tachyarrhythmias caused by chronic use of CGs( in acute CG toxicity plasma K+ is increased and contraindicated)
Use of antiarrhythmic drugs
(lidocaine for ventricular arrhythmias; propranolol supraventricular arrhythmias; atropine for AV-block and bradycardia)
Digoxin antibodies for severe toxicity(binds digoxin and digitoxin and enhances their excretion by kidney
Precautions and contraindications:
hypokalemic patients
k competetive inhibits digoxin
Elderly, renal or severe hepatic disease
Myocardial infraction
Thyrotoxicosis
Ventricular tachycardia
interactions with
diuretics
calcium
quinidine
antacids
phenobarbitone
Diuretics: cause hypokalemia(K+ supplementation may be given prophylactically)
Calcium: synergizes with digitalis and precipitates toxicity
Quinidine: displaces digoxin from plasma proteins
Antacids: decrease digoxin absorption
Phenobarbitone: enhance metabolism of digitoxin and decrease its half-life
Bipyridines
are termed as phosphodiesterase inhibitors
Representatives include inamrinone, milrinone
Increase force of contraction
Produce vasodilatation(arteries and veins)
Act by inhibiting phosphodiesterase isoenzyme III(found in heart & blood vessels)
moa of bipyridines
Phosphodiesterase is an enzyme that catalyzes the inactivation of cAMP
PDEIs result in increased concentration of cAMP
adverse effects of Bipyridines
Nausea, vomiting, arrhythmia, thrombocytopenia and liver toxicity are adverse effects( but milrinone better tolerated)
Beta agonists in HF
dobutamine and dopamine are positive inotropic agents of choice for the short-term support of circulation in advanced heart failure(in ICUs preferred to bipyridines)
Dobutamine has lesser effect on heart rate as compared to other sypmathomimetics
Dopamine improves renal perfusion additionally(advantageous in shock)